Emcure Pharmaceuticals, on August 19 filed its Draft Red Hearing Prospectus (DRHP) with market regulator Securities and Exchange Board of India (SEBI) for its proposed initial public offer (IPO).

Market sources told Moneycontrol that the IPO size would be in the range of of Rs 4500 crore – Rs 5000 crore.

On October 22, 2019, Moneycontrol was the first to report that Emcure Pharma would pursue an internal rejig and then revive its listing plans

Leave a Reply

Your email address will not be published. Required fields are marked *

Emcure Pharmaceuticals, on August 19 filed its Draft Red Hearing Prospectus (DRHP) with market regulator Securities and Exchange Board of India (SEBI) for its proposed initial public offer (IPO).

Market sources told Moneycontrol that the IPO size would be in the range of of Rs 4500 crore – Rs 5000 crore.

On October 22, 2019, Moneycontrol was the first to report that Emcure Pharma would pursue an internal rejig and then revive its listing plans

Leave a Reply

Your email address will not be published. Required fields are marked *